Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T lymphocytes, commonly referred to as regulatory T cells or Tregs, are a specialized subset of CD4+ T cells characterized by the expression of the transcription factor FoxP3. These cells play a critical role in maintaining immune system balance by suppressing excessive immune responses and promoting self-tolerance, thereby preventing autoimmune diseases. Tregs achieve these effects through multiple mechanisms: secretion of inhibitory cytokines such as IL-10, IL-35, and transforming growth factor-beta (TGF‑β), induction of apoptosis in target effector cells via granzyme B/perforin pathways and Modulation of antigen-presenting cell function through molecules like CTLA‑4.
Modulation of immune responses through cytokine secretion (IL-10, IL-35, TGF-β), cytolysis (granzyme B/perforin), metabolic disruption (IL-2 consumption, adenosine production), and APC modulation (CTLA-4)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory T Lymphocyte (CD4+ FoxP3+) (Treg).